Current Report Filing (8-k)
January 31 2022 - 6:49AM
Edgar (US Regulatory)
0001805087
false
0001805087
2022-01-31
2022-01-31
0001805087
us-gaap:CommonStockMember
2022-01-31
2022-01-31
0001805087
GLS:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member
2022-01-31
2022-01-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
January 31, 2022
Gelesis Holdings, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware
|
|
001-39362
|
|
84-4730610
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
501 Boylston Street, Suite 6102, Boston,
MA 02116
(Address of Principal Executive Offices) (Zip Code)
(617)
456-4718
(Registrant’s telephone number, including
area code)
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
Trading
Symbol(s)
|
Name of each exchange on which
registered
|
Common Stock, par value $0.0001 per share
|
GLS
|
The New York Stock Exchange
|
Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
|
GLS WS
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
On
January 31, 2022, Gelesis Holdings, Inc. issued a press release announcing the debut of its “Who Said” media campaign.
A copy of the press release is filed hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: January 31, 2022
|
GELESIS HOLDINGS INC.
|
|
|
|
By:
|
/s/ Elliot Maltz
|
|
Name:
|
Elliot Maltz
|
|
Title:
|
Chief Financial Officer
|
Gelesis (NYSE:GLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gelesis (NYSE:GLS)
Historical Stock Chart
From Apr 2023 to Apr 2024